Loss-of-SIRT1 function during vascular ageing: Hyperphosphorylation mediated by cyclin-dependent kinase 5

Trends in Cardiovascular Medicine

Volumn 24, Issue 2, 2014, Pages 81-84

  Bai, Bo ^a   Vanhoutte, Paul M ^a   Wang, Yu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; SIRTUIN 1;

AGING; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR SYSTEM; CELL AGING; DEACETYLATION; DISEASE COURSE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; ENZYME REGULATION; LONGEVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SENESCENCE;

AGE FACTORS; AGING; ANIMALS; ARTERIES; ATHEROSCLEROSIS; CYCLIN-DEPENDENT KINASE 5; ENDOTHELIAL CELLS; HUMANS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SIRTUIN 1;

EID: 84891947918     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.07.001     Document Type: Review

References (46)

1. Abdelmohsen K., Pullmann R., Lal A., et al. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 2007, 25:543-557.
2. Arif A. Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5. Biochem Pharmacol 2012, 84:985-993.
3. Bai B., Liang Y., Xu C., et al. Cyclin-dependent kinase 5-mediated hyperphosphorylation of sirtuin-1 contributes to the development of endothelial senescence and atherosclerosis. Circulation 2012, 126:729-740.
4. Bai B., Wang Y. Methods to investigate the role of SIRT1 in endothelial senescence. Cell Senescence, Methods in Molecular Biology 2012, 965. Springer.
5. Berberich N., Uhl B., Joore J., et al. Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9. Br J Pharmacol 2011, 163:1086-1098.
6. Bukanov N.O., Smith L.A., Klinger K.W., Ledbetter S.R., Ibraghimov-Beskrovnaya O. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 2006, 444:949-952.
7. Chen H.Z., Wan Y.Z., Liu D.P. Cross-talk between SIRT1 and p66Shc in vascular diseases. Trends Cardiovasc Med 2013.
8. Cho D.H., Seo J., Park J.H., et al. Cyclin-dependent kinase 5 phosphorylates endothelial nitric oxide synthase at serine 116. Hypertension 2010, 55:345-352.
9. Cicero S., Herrup K. Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J Neurosci 2005, 25:9658-9668.
10. Demange L., Abdellah F.N., Lozach O., et al. Potent inhibitors of CDK5 derived from roscovitine: synthesis, biological evaluation and molecular modelling. Bioorg Med Chem Lett 2013, 23:125-131.
11. Donato A.J., Magerko K.A., Lawson B.R., Durrant J.R., Lesniewski L.A., Seals D.R. SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J Physiol 2011, 589:4545-4554.
12. Erusalimsky J.D. Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol 2009, 106:326-332.
13. Flick F., Luscher B. Regulation of sirtuin function by posttranslational modifications. Front Pharmacol 2012, 3:29.
14. Ghosh A.S., Tergaonkar V. Telomeres and inflammation: Rap1 joins the ends?. Cell Cycle 2010, 9:3834-3835.
15. Han L., Zhou R., Niu J., McNutt M.A., Wang P., Tong T. SIRT1 is regulated by a PPAR (gamma)-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res 2010.
16. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37:614-636.
17. Hellmich M.R., Pant H.C., Wada E., Battey J.F. Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc Natl Acad Sci U S A 1992, 89:10867-10871.
18. Hisanaga S., Saito T. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator. Neurosignals 2003, 12:221-229.
19. +-dependent protein deacetylase SIRT1 by nuclear receptor TLX. Biochem Biophys Res Commun 2009, 386:671-675.
20. Kaeberlein M., McVey M., Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 1999, 13:2570-2580.
21. Kang H., Jung J.W., Kim M.K., Chung J.H. CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage. PLoS One 2009, 4:e6611.
22. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes Dev 2010, 24:2463-2479.
23. Lalioti V., Pulido D., Sandoval I.V. Cdk5, the multifunctional surveyor. Cell Cycle 2010, 9:284-311.
24. Lee C.H., Wei Y.W., Huang Y.T., et al. CDK5 phosphorylates eNOS at Ser-113 and regulates NO production. J Cell Biochem 2010, 110:112-117.
25. Lee M.Y., Wang Y., Vanhoutte P.M. Senescence of cultured porcine coronary arterial endothelial cells is associated with accelerated oxidative stress and activation of NFkB. J Vasc Res 2010, 47:287-298.
26. Liebl J., Furst R., Vollmar A.M., Zahler S. Twice switched at birth: cell cycle-independent roles of the "neuron-specific" cyclin-dependent kinase 5 (Cdk5) in non-neuronal cells. Cell Signal 2011, 23:1698-1707.
27. Liebl J., Weitensteiner S.B., Vereb G., et al. Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis. J Biol Chem 2010, 285:35932-35943.
28. Liu N.A., Jiang H., Ben-Shlomo A., et al. Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor. Proc Natl Acad Sci U S A 2011, 108:8414-8419.
29. + sensing receptor cleavage by calpain partially accounts for altered vascular reactivity in mice fed a high fat diet. J Cardiovasc Pharmacol 2013.
30. Menghini R., Casagrande V., Cardellini M., et al. Micro RNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009, 120:1524-1532.
31. Miyazaki T., Koya T., Kigawa Y., et al. Calpain and atherosclerosis. J Atheroscler Thromb 2013, 20:228-237.
32. Nasrin N., Kaushik V.K., Fortier E., et al. JNK1 phosphorylates SIRT1 and promotes its enzymatic activity. PLoS One 2009, 4:e8414.
33. Orimo M., Minamino T., Miyauchi H., et al. Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler Thromb Vasc Biol 2009, 29:889-894.
34. Ota H., Akishita M., Eto M., Iijima K., Kaneki M., Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 2007, 43:571-579.
35. Ota H., Eto M., Ogawa S., Iijima K., Akishita M., Ouchi Y. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J Atheroscler Thromb 2010, 17:431-435.
36. Potente M. An energy-sensor network takes center stage during endothelial aging. Circ Res 2010, 106:1316-1318.
37. Randriamboavonjy V., Fleming I. The role of calpain in diabetes-associated platelet hyperactivation. Adv Pharmacol 2010, 59:235-257.
38. Wang C., Chen L., Hou X., et al. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol 2006, 8:1025-1031.
39. Wang J.C., Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 2012, 111:245-259.
40. Wang Y., Liang Y., Vanhoutte P.M. SIRT1 and AMPK in regulating mammalian senescence: a critical review and a working model. FEBS Lett 2011, 585:986-994.
41. Wang Y., Xu C., Liang Y., Vanhoutte P.M. SIRT1 in metabolic syndrome: where to target matters. Pharmacol Ther 2012, 136:305-318.
42. Xiong S., Salazar G., Patrushev N., Alexander R.W. FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J Biol Chem 2011, 286:5289-5299.
43. Yamakuchi M. MicroRNA regulation of SIRT1. Front Physiol 2012, 3:68.
44. Yeung F., Hoberg J.E., Ramsey C.S., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004, 23:2369-2380.
45. Zschoernig B., Mahlknecht U. Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2. Biochem Biophys Res Commun 2009, 381:372-377.
46. Zu Y., Liu L., Lee M.Y., et al. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res 2010, 106:1384-1393.